---
title: Combination drug screen identifies synergistic drug interaction of BCL-XL and
  class I histone deacetylase inhibitors in MYC-amplified medulloblastoma cells
date: '2024-01-07'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38184819/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240107170847&v=2.18.0
source: heidelberg[Affiliation]
description: 'CONCLUSION: Our study identifies the combination of class I HDACi and
  BCL-XL inhibitors as a potential new approach for the treatment of MYC-amplified
  MB cells. Graphical abstract created with BioRender.com, illustrating the workflow
  and summarizing main ...'
disable_comments: true
---
CONCLUSION: Our study identifies the combination of class I HDACi and BCL-XL inhibitors as a potential new approach for the treatment of MYC-amplified MB cells. Graphical abstract created with BioRender.com, illustrating the workflow and summarizing main ...